Impax Asset Management Group plc cut its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,451 shares of the medical instruments supplier’s stock after selling 216 shares during the period. […]
Impax Asset Management Group plc trimmed its position in Insulet Co. (NASDAQ:PODD – Free Report) by 13.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,451 shares of the medical instruments supplier’s stock after selling 216 shares during the period. Impax Asset Management Group plc’s holdings in Insulet were worth $315,000 as […]
Eastern Bank lowered its position in Insulet Co. (NASDAQ:PODD – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 49,910 shares of the medical instruments supplier’s stock after selling 1,319 shares during the quarter. Eastern Bank owned […]
Camelot Portfolios LLC acquired a new position in Insulet Co. (NASDAQ:PODD – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,153 shares of the medical instruments supplier’s stock, valued at approximately $250,000. Other hedge funds have also recently made changes […]
Camelot Portfolios LLC purchased a new position in shares of Insulet Co. (NASDAQ:PODD – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,153 shares of the medical instruments supplier’s stock, valued at approximately $250,000. A number of other institutional investors […]